0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Cell > GLP1R > CHEK-ATP160

HEK293/Human GLP-1R Stable Cell Line (High Expression)

Order Now

  1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
  2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
  3. Comprehensive application data to support assay development and validation
  4. Full tracible record, stringent quality control and validated cell passage stability
  5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
  6. Global commercial license assistance whenever regulatory filing is required
  • Description
    The HEK293/Human GLP-1R Stable Cell Line was engineered to express the receptor full length human GLP-1R (Gene ID: 2740), with different levels of GLP-1R expression (High, Medium, Low). Surface expression of human GLP-1R was confirmed by flow cytometry.
  • Application

    • Useful for cell-based GLP-1R binding assay

    • Screen for human GLP-1R agonists based on cAMP accumulation assay

  • Growth Properties
    Adherent
  • Selection Marker
    Hygromycin (20 μg/mL)
  • Culture Medium
    DMEM + 10% FBS
  • Freeze Medium
    Serum-free cell cryopreservation medium
  • Quantity
    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium
  • Storage
    Frozen in liquid nitrogen.
  • Mycoplasma Testing
    Negative
  • Sterility Testing
    Negative
  • Instructions for Use
    See data sheet for detailed culturing and assay protocol.
Receptor Assay
 GLP1R FACS

Expression analysis of human GLP-1R on HEK293/Human GLP-1R Stable Cell Line by FACS.
Cell surface staining using PE-labeled anti-human GLP-1R antibody was performed on HEK293/Human GLP-1R Stable Cell Line with different expression levels: HEK293/Human GLP-1R Stable Cell Line (Low Expression); HEK293/Human GLP-1R Stable Cell Line (Medium Expression); HEK293/Human GLP-1R Stable Cell Line (High Expression).

Application
 GLP1R APPLICATION

cAMP accumulation assay for human GLP-1R agonist screening.
HEK293/Human GLP-1R Stable Cell Line (Low Expression), HEK293/Human GLP-1R Stable Cell Line (Medium Expression) and HEK293/Human GLP-1R Stable Cell Line (High Expression) were stimulated with Tirzepatide, respectively. The EC50 of Tirzepatide on HEK293/Human GLP-1R Stable Cell Line (High Expression) was approximately 0.0001544 μM.

Passage Stability
 GLP1R PASSAGE

Passage stability analysis of receptors expression by FACS.
Flow cytometry surface staining of human GLP-1R on HEK293/Human GLP-1R Stable Cell Line (High Expression) demonstrates consistent mean fluorescent intensity across passage 7-22.

Please contact us if you are interested in related cell pool service.

  • Background
    This gene encodes a 7-transmembrane protein that functions as a receptor for glucagon-like peptide 1 (GLP-1) hormone, which stimulates glucose-induced insulin secretion. This receptor, which functions at the cell surface, becomes internalized in response to GLP-1 and GLP-1 analogs, and it plays an important role in the signaling cascades leading to insulin secretion. It also displays neuroprotective effects in animal models. Polymorphisms in this gene are associated with diabetes. The protein is an important drug target for the treatment of type 2 diabetes and stroke.
  • Limited Use&License Disclosure
    1. This cell line is provided for research use only. It is neither intended for any animal or human therapeutic use nor for any direct human in vivo use. You are restricted to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
    2. ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
    3. ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
    4. Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order@acrobiosystems.com for further details.
  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €3540.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:1 Details
  • Latest Research Phase:Phase 1 Clinical

Datasheet & Documentation

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message